| Lastest Insider Transactions Of Tango Therapeutics, Inc. ( TNGX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-09-01 | Sell | 27,000 | 22.37 | 603,909 | 2026-09-03 16:01:04 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-09-01 | Option Exercise | 27,000 | 5.20 | 140,400 | 2026-09-03 16:01:04 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-08-03 | Sell | 27,000 | 27.24 | 735,517 | 2026-08-05 16:01:03 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-08-03 | Option Exercise | 27,000 | 5.20 | 140,400 | 2026-08-05 16:01:03 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-07-01 | Sell | 27,000 | 29.59 | 798,908 | 2026-07-02 19:23:37 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-07-01 | Option Exercise | 27,000 | 5.20 | 140,400 | 2026-07-02 19:23:37 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-06-01 | Sell | 27,000 | 22.87 | 617,571 | 2026-06-03 18:37:29 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-06-01 | Option Exercise | 27,000 | 5.20 | 140,400 | 2026-06-03 18:37:29 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-05-01 | Sell | 27,000 | 21.23 | 573,097 | 2026-05-05 19:47:10 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-05-01 | Option Exercise | 27,000 | 5.20 | 140,400 | 2026-05-05 19:47:10 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-04-15 | Sell | 38,460 | 25.00 | 961,500 | 2026-04-16 20:14:04 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-04-15 | Option Exercise | 38,460 | 5.20 | 199,992 | 2026-04-16 20:14:04 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-04-01 | Sell | 27,000 | 21.20 | 572,478 | 2026-04-02 20:09:07 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-04-01 | Option Exercise | 27,000 | 5.20 | 140,400 | 2026-04-02 20:09:07 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-03-25 | Sell | 12,000 | 20.11 | 241,320 | 2026-03-27 20:06:56 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-03-25 | Option Exercise | 12,000 | 5.20 | 62,400 | 2026-03-27 20:06:56 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-03-05 | Sell | 20,251 | 15.00 | 303,765 | 2026-03-09 16:01:04 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-02-25 | Sell | 54,345 | 12.77 | 694,208 | 2026-02-27 18:54:34 |
| TNGX | Tango Therapeutics, Inc. | Beckman Daniella | Chief Financial Officer | 2026-02-02 | Sell | 10,317 | 12.26 | 126,531 | 2026-02-04 20:12:01 |
| TNGX | Tango Therapeutics, Inc. | Weber Barbara | Director, Executive Chair | 2026-02-02 | Sell | 30,519 | 12.26 | 374,294 | 2026-02-04 20:09:06 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | 2026-02-02 | Sell | 18,452 | 12.26 | 226,300 | 2026-02-04 20:02:17 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2025-10-23 | Sell | 477,401 | 10.15 | 4,846,575 | 2025-10-27 16:15:03 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2025-09-25 | Sell | 500,000 | 8.02 | 4,008,500 | 2025-09-29 16:15:05 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2025-09-16 | Sell | 363,541 | 7.04 | 2,559,329 | 2025-09-17 18:06:13 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2025-09-05 | Sell | 729,365 | 7.00 | 5,108,970 | 2025-09-09 16:15:06 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2025-08-22 | Sell | 302,194 | 7.00 | 2,115,358 | 2025-08-26 16:15:09 |
| TNGX | Tango Therapeutics, Inc. | Barry Douglas | General Counsel | 2025-02-04 | Sell | 5,330 | 3.07 | 16,369 | 2025-02-06 20:21:04 |
| TNGX | Tango Therapeutics, Inc. | Beckman Daniella | Chief Financial Officer | 2025-02-04 | Sell | 8,232 | 3.07 | 25,282 | 2025-02-06 20:10:55 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | 2025-02-04 | Sell | 14,283 | 3.07 | 43,866 | 2025-02-06 20:08:43 |
| TNGX | Tango Therapeutics, Inc. | Weber Barbara | Chief Executive Officer | 2025-02-04 | Sell | 18,791 | 3.07 | 57,710 | 2025-02-06 20:02:12 |
| TNGX | Tango Therapeutics, Inc. | Rothenberg Mace | Directior | 2024-11-14 | Buy | 20,000 | 3.70 | 74,000 | 2024-11-18 19:20:03 |
| TNGX | Tango Therapeutics, Inc. | EcoR1 Capital, LLC | 10% Owner | 2024-11-06 | Sell | 2,700,000 | 3.12 | 8,435,743 | 2024-11-08 19:24:48 |
| TNGX | Tango Therapeutics, Inc. | Boxer Capital Management, LLC | | 2024-11-06 | Sell | 3,080,000 | 3.14 | 9,671,200 | 2024-11-07 21:30:23 |
| TNGX | Tango Therapeutics, Inc. | Boxer Capital Management, LLC | | 2024-10-25 | Sell | 633,000 | 6.87 | 4,348,710 | 2024-10-28 06:59:22 |
| TNGX | Tango Therapeutics, Inc. | Boxer Capital Management, LLC | | 2024-10-21 | Sell | 875,000 | 6.97 | 6,101,250 | 2024-10-23 21:31:42 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-09-13 | Sell | 67,400 | 10.53 | 709,756 | 2024-09-17 16:48:33 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-08-16 | Sell | 285,000 | 9.95 | 2,835,368 | 2024-08-20 17:59:38 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-07-26 | Sell | 50,000 | 9.84 | 491,950 | 2024-07-30 16:15:03 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-07-24 | Sell | 300,599 | 9.83 | 2,955,931 | 2024-07-26 16:15:03 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-07-22 | Sell | 387,740 | 9.78 | 3,793,447 | 2024-07-24 16:15:03 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-07-18 | Sell | 191,490 | 9.81 | 1,878,479 | 2024-07-22 16:15:03 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-07-17 | Sell | 550,171 | 9.79 | 5,386,339 | 2024-07-18 16:15:03 |
| TNGX | Tango Therapeutics, Inc. | MVA Investors, LLC | | 2024-06-28 | Sell | 234,731 | 8.76 | 2,055,314 | 2024-07-02 20:56:42 |
| TNGX | Tango Therapeutics, Inc. | MVA Investors, LLC | | 2024-06-06 | Sell | 140,000 | 7.04 | 985,880 | 2024-06-07 21:14:32 |
| TNGX | Tango Therapeutics, Inc. | Calhoun Lesley Ann | Directior | 2024-06-05 | Sell | 5,000 | 7.21 | 36,039 | 2024-06-07 17:16:19 |
| TNGX | Tango Therapeutics, Inc. | MVA Investors, LLC | | 2024-05-01 | Sell | 210,000 | 7.53 | 1,580,850 | 2024-05-03 21:34:33 |
| TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 10% Owner | 2024-02-20 | Sell | 162,500 | 12.00 | 1,950,000 | 2024-02-21 17:52:28 |
| TNGX | Tango Therapeutics, Inc. | Weber Barbara | Chief Executive Officer | 2024-02-06 | Sell | 9,138 | 12.59 | 115,052 | 2024-02-08 21:14:25 |
| TNGX | Tango Therapeutics, Inc. | Barry Douglas | General Counsel | 2024-02-06 | Sell | 2,776 | 12.59 | 34,951 | 2024-02-08 21:09:14 |
| TNGX | Tango Therapeutics, Inc. | Beckman Daniella | Chief Financial Officer | 2024-02-06 | Sell | 3,725 | 12.59 | 46,900 | 2024-02-08 21:08:42 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | 2024-02-06 | Sell | 8,371 | 12.59 | 105,395 | 2024-02-08 21:04:52 |
| TNGX | Tango Therapeutics, Inc. | Crystal Adam | See Remarks | 2023-11-01 | Sell | 7,507 | 8.39 | 62,994 | 2023-11-02 16:49:54 |
| TNGX | Tango Therapeutics, Inc. | Boxer Capital, LLC | | 2023-10-13 | Buy | 1,250,000 | 6.98 | 8,722,500 | 2023-10-17 19:41:18 |
| TNGX | Tango Therapeutics, Inc. | Boxer Capital, LLC | | 2023-10-13 | Buy | 1,250,000 | 6.98 | 8,722,500 | 2023-10-17 18:04:34 |
| TNGX | Tango Therapeutics, Inc. | Boxer Capital, LLC | | 2023-10-09 | Sell | 225,000 | 9.96 | 2,240,250 | 2023-10-11 21:22:57 |
| TNGX | Tango Therapeutics, Inc. | Boxer Capital, LLC | | 2023-08-11 | Buy | 475,000 | 5.15 | 2,446,250 | 2023-08-15 21:34:39 |
